Drug Type Small molecule drug |
Synonyms MK 0472, MK0472 |
Target |
Action inhibitors |
Mechanism SHP2 inhibitors(Src homology phosphotyrosyl phosphatase 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Advanced Malignant Solid Neoplasm | Phase 1 | United States | 06 Jul 2023 | |
| Advanced Malignant Solid Neoplasm | Phase 1 | Canada | 06 Jul 2023 | |
| Advanced Malignant Solid Neoplasm | Phase 1 | Chile | 06 Jul 2023 | |
| Advanced Malignant Solid Neoplasm | Phase 1 | Israel | 06 Jul 2023 | |
| Advanced Malignant Solid Neoplasm | Phase 1 | Poland | 06 Jul 2023 | |
| Advanced Malignant Solid Neoplasm | Phase 1 | Spain | 06 Jul 2023 | |
| Advanced Malignant Solid Neoplasm | Phase 1 | Switzerland | 06 Jul 2023 | |
| Metastatic Solid Tumor | Phase 1 | United States | 06 Jul 2023 | |
| Metastatic Solid Tumor | Phase 1 | Canada | 06 Jul 2023 | |
| Metastatic Solid Tumor | Phase 1 | Chile | 06 Jul 2023 |





